The Role of Cyclic Adenosine Monophosphate in Adrenergic Effects on Ventricular Vulnerability to Fibrillation in the Isolated Perfused Rat Heart

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1978 May 1

PMID 207734

Citations 11

Authors

W F Lubbe

T Podzuweit

P S Daries

L H Opie

Affiliations

Soon will be listed here.

Abstract

The relation between myocardial tissue cyclic AMP (cAMP) and the vulnerability to ventricular fibrillation was assessed in the isolated perfused rat heart by measurement of ventricular fibrillation threshold (VFT) and vulnerable period duration (VP). Exogenous dibutyryl cyclic AMP (DBcAMP) reduced VFT and increased VP by a concentration-related action whereas exogenous cAMP did not. Theophylline (1.0 mmol/liter) increased the tissue content of cAMP by 58% (P < 0.001) and caused a leftward shift in the concentration-response curve to DBcAMP. An effect of cAMP on VFT and VP could be shown in the presence of phosphodiesterase inhibition by theophylline. beta-1-Adrenergic receptor blockade with atenolol did not alter the concentration-response curve for VFT when DBcAMP was administered. Epinephrine (100 nmol/liter to 1 mumol/liter) also increased vulnerability to VF; this effect was accompanied by a concentration-related increase in tissue cAMP, but inconsistent changes in tissue ATP, phosphocreatine and potassium. The concentration-response curve of VFT to epinephrine was shifted leftward by theophylline and rightward by atenolol. The increases in vulnerability to fibrillation in the isolated perfused rat heart, in response to DBcAMP, theophylline or epinephrine, could be related more closely to changes of tissue cAMP than to effects on tissue high energy phosphates or potassium. The effect of epinephrine and theophylline on vulnerability to ventricular fibrillation is mediated via alterations in the intracellular level of cAMP in the isolated perfused rat heart.

Citing Articles

Effect of levosimendan on myocardial contractility, coronary and peripheral blood flow, and arrhythmias during coronary artery ligation and reperfusion in the in vivo pig model.

Du Toit E, Hofmann D, McCarthy J, Pineda C Heart. 2001; 86(1):81-7.

PMID: 11410569 PMC: 1729816. DOI: 10.1136/heart.86.1.81.

Reversal of lidocaine effects on sodium currents by isoproterenol in rabbit hearts and heart cells.

Lee H, Matsuda J, Reynertson S, Martins J, Shibata E J Clin Invest. 1993; 91(2):693-701.

PMID: 8381826 PMC: 288011. DOI: 10.1172/JCI116250.

Phosphodiesterase III inhibitors: long-term risks and short-term benefits.

Cruickshank J Cardiovasc Drugs Ther. 1993; 7(4):655-60.

PMID: 8241008 DOI: 10.1007/BF00877818.

The interaction of calcium and cAMP and the relationship to ventricular vulnerability.

Thandroyen F, Higginson L, Opie L Basic Res Cardiol. 1981; 76(4):449-52.

PMID: 6269528 DOI: 10.1007/BF01908340.

Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.

Opie L Cardiovasc Drugs Ther. 1988; 1(5):461-91.

PMID: 3154677 DOI: 10.1007/BF02125731.

References

Lubbe W, Bricknell O, Podzuweit H . Cyclic AMP as a determinant of vulnerability to ventricular fibrillation in the isolated rat heart. Cardiovasc Res. 1976; 10(6):697-702. DOI: 10.1093/cvr/10.6.697. View

Cheung W, Williamson J . Kinetics of cyclic adenosine monophosphate changes in rat heart following epinephrine administration. Nature. 1965; 207(5000):979-81. DOI: 10.1038/207979b0. View

Reuter H . Localization of beta adrenergic receptors, and effects of noradrenaline and cyclic nucleotides on action potentials, ionic currents and tension in mammalian cardiac muscle. J Physiol. 1974; 242(2):429-51. PMC: 1330676. DOI: 10.1113/jphysiol.1974.sp010716. View

WOLLENBERGER A, Krause E, Heier G . Stimulation of 3',5'-cyclic AMP formation in dog myocardium following arrest of blood flow. Biochem Biophys Res Commun. 1969; 36(4):664-70. DOI: 10.1016/0006-291x(69)90357-x. View

Tsien R . Adrenaline-like effects of intracellular iontophoresis of cyclic AMP in cardiac Purkinje fibres. Nat New Biol. 1973; 245(143):120-2. DOI: 10.1038/newbio245120a0. View

Wilhelmsson C, Vedin J, Wilhelmsen L, Tibblin G, WERKO L . Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results. Lancet. 1974; 2(7890):1157-60. DOI: 10.1016/s0140-6736(74)90807-1. View

Darby S, Cruickshank J, Bennett M, PENTECOST B . Trial of combined intramuscular and intravenous lignocaine in prophylaxis of ventricular tachyarrhythmias. Lancet. 1972; 1(7755):817-9. DOI: 10.1016/s0140-6736(72)90801-x. View

Jewitt D, Reid D, Thomas M, Mercer C, VALORI C, Shillingford J . Free noradrenaline and adrenaline excretion in relation to the development of cardiac arrhythmias and heart-failure in patients with acute myocardial infarction. Lancet. 1969; 1(7596):635-41. DOI: 10.1016/s0140-6736(69)92009-1. View

Han J . Ventricular vulnerability during acute coronary occlusion. Am J Cardiol. 1969; 24(6):857-64. DOI: 10.1016/0002-9149(69)90476-7. View

10.

Schaffer W, Cobb L . Recurrent ventricular fibrillation and modes of death in survivors of out-of-hospital ventricular fibrillation. N Engl J Med. 1975; 293(6):259-62. DOI: 10.1056/NEJM197508072930601. View

11.

Khan M, Hamilton J, MANNING G . Protective effect of beta adrenoceptor blockade in experimental coronary occlusion in conscious dogs. Am J Cardiol. 1972; 30(8):832-7. DOI: 10.1016/0002-9149(72)90007-0. View

12.

Brown B, Albano J, Ekins R, Sgherzi A . A simple and sensitive saturation assay method for the measurement of adenosine 3':5'-cyclic monophosphate. Biochem J. 1971; 121(3):561-2. PMC: 1176606. DOI: 10.1042/bj1210561. View

13.

Fox K, Chopra M, Portal R, Aber C . Long-term beta blockade: possible protection from myocardial infarction. Br Med J. 1975; 1(5950):117-9. PMC: 1671936. DOI: 10.1136/bmj.1.5950.117. View

14.

Podzuweit T, Lubbe W, Opie L . Cyclic adenosine monophosphate, ventricular fibrillation, and antiarrhythmic drugs. Lancet. 1976; 1(7955):341-2. DOI: 10.1016/s0140-6736(76)90090-8. View

15.

Schneider J, Sperelakis N . Slow Ca2+ and Na+ responses induced by isoproterenol and methylxanthines in isolated perfused guinea pig hearts exposed to elevated K+. J Mol Cell Cardiol. 1975; 7(4):249-73. DOI: 10.1016/0022-2828(75)90084-x. View

16.

SUTHERLAND E, Robison G . The role of cyclic-3',5'-AMP in responses to catecholamines and other hormones. Pharmacol Rev. 1966; 18(1):145-61. View

17.

MEESMANN W, Gulker H, Kramer B, Stephan K . Time course of changes in ventricular fibrillation threshold in myocardial infarction: characteristics of acute and slow occlusion with respect to the collateral vessels of the heart. Cardiovasc Res. 1976; 10(4):466-73. DOI: 10.1093/cvr/10.4.466. View

18.

Borer J, Harrison L, Kent K, Levy R, Goldstein R, Epstein S . Beneficial effect of lidocaine on ventricular electrical stability and spontaneous ventricular fibrillation during experimental myocardial infarction. Am J Cardiol. 1976; 37(6):860-3. DOI: 10.1016/0002-9149(76)90110-7. View

19.

WOLLENBERGER A, Ristau O, SCHOFFA G . [A simple technic for extremely rapid freezing of large pieces of tissue]. Pflugers Arch Gesamte Physiol Menschen Tiere. 1960; 270:399-412. View

20.

POSTERNAK T, SUTHERLAND E, HENION W . Derivatives of cyclic 3',5'-adenosine monophosphate. Biochim Biophys Acta. 1962; 65:558-60. DOI: 10.1016/0006-3002(62)90475-4. View